Ann Thorac Surg

1. RUCKER AJ, D'Amico TA, Pappas TN
   Ivor Lewis Esophagectomy and the Care of Humphrey Bogart's Mid-Esophageal Cancer.
   Ann Thorac Surg. 2024 Apr 12:S0003-4975(24)00278.
   

   >> Share

   
   

   
   BMC Cancer

2. CHEN Y, Huang Y, Chen X, Chen Z, et al
   Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
   BMC Cancer. 2024;24:483.
   

   >> Share

   
   
3. MALEKI Z, Hassanzadeh J, Ghaem H
   Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.
   BMC Cancer. 2024;24:467.
   

   >> Share

   
   
4. DONG Z, Wang GY, Dai DY, Qin GJ, et al
   Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
   BMC Cancer. 2024;24:466.
   

   >> Share

   
   
5. ELTOHAMI Y, Suleiman A
   Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
   BMC Cancer. 2024;24:473.
   

   >> Share

   
   
6. MAN Q, Li P, Fan J, Yang S, et al
   The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
   BMC Cancer. 2024;24:464.
   

   >> Share

   
   
7. YANG Y, Yi Y, Wang Z, Li S, et al
   A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
   BMC Cancer. 2024;24:460.
   

   >> Share

   
   
8. IDEL C, Fleckner J, Plotze-Martin K, Werner L, et al
   Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11.
   BMC Cancer. 2024;24:459.
   

   >> Share

   
   
9. JOHANSSON B, Cajander A, Ahmad A, Ohlsson-Nevo E, et al
   The effect of internet-administered support (carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer compared with support as usual: a study protocol for a randomized controlled trial.
   BMC Cancer. 2024;24:494.
   

   >> Share

   
   
10. CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
    Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
    BMC Cancer. 2024;24:487.
    

    >> Share

    
    

    
    Head Neck

11. SINGH A, Sullivan R, Bavaskar M, Shetty R, et al
    A prospective health economic evaluation to determine the productivity loss due to premature mortality from oral cancer in India.
    Head Neck. 2024 Apr 15. doi: 10.1002/hed.27776.
    

    >> Share

    
    
12. FAY M, Clavijo PE, Allen CT
    Heterogeneous characterization of neutrophilic cells in head and neck cancers.
    Head Neck. 2024 Apr 15. doi: 10.1002/hed.27774.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

13. MCVORRAN S, Naghavi A, Schaner P
    Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?
    Int J Radiat Oncol Biol Phys. 2024;119:302-303.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

14. TODA S, Hiroshima Y, Iwasaki H, Masudo K, et al
    Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan.
    J Clin Endocrinol Metab. 2024 Apr 17:dgae271. doi: 10.1210.
    

    >> Share

    
    

    
    J Clin Oncol

15. PENG X, Li Z, Pei Y, Zheng S, et al
    Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial.
    J Clin Oncol. 2024;42:1426-1435.
    

    >> Share

    
    
16. WARDILL HR, Bossi P, Sonis ST
    Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis.
    J Clin Oncol. 2024;42:1436-1438.
    

    >> Share

    
    

    
    J Oral Maxillofac Surg

17. BAO X, Chen F, Liu F, Qiu Y, et al
    Preoperative Serum Selenium Concentrations and Disease-Specific Survival in Patients With Oral Cancer: A Long-Term Follow-Up Study.
    J Oral Maxillofac Surg. 2024 Apr 2:S0278-2391(24)00211.
    

    >> Share

    
    

    
    Oral Oncol

18. SMITH JD, Heft-Neal ME, Rosko AJ, Chepeha DB, et al
    Upfront neck dissection to guide single-modality therapy for early stage supraglottic squamous cell carcinoma.
    Oral Oncol. 2024;152:106803.
    

    >> Share

    
    
19. RICARDO ELIAS DE MELO P, Agra Monteiro M, Henrique Rocha Aragao H, Vitoria de Araujo Lopes N, et al
    Comment on "Awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?".
    Oral Oncol. 2024;152:106802.
    

    >> Share

    
    
20. SARAVANAN M
    Comment on "Nanomedicine, an emerging therapeutic strategy for oral cancer therapy".
    Oral Oncol. 2024;152:106806.
    

    >> Share

    
    
21. SEKAR D
    Comment on betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study.
    Oral Oncol. 2024;152:106800.
    

    >> Share

    
    
22. RAMASAMY P, Sekaran S, Ganapathy D
    Oral cancer burden in tribal populations residing in India.
    Oral Oncol. 2024;152:106801.
    

    >> Share

    
    
23. LI Y, Zhou Y, Zhao C, Liu L, et al
    The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-beta1/Smads/Snail1 axis.
    Oral Oncol. 2024;152:106798.
    

    >> Share

    
    
24. YEO BSY, Lee RS, Lim NE, Tan E, et al
    Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma - A Systematic Review and Meta-analysis.
    Oral Oncol. 2024;152:106786.
    

    >> Share

    
    
25. FANG Q, Yuan J, Zhang X, Dai L, et al
    Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
    Oral Oncol. 2024;152:106810.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

26. PATEL AM, Haleem A, Choudhry HS, Brody RM, et al
    Elective Neck Dissection in cT1-4 N0M0 Head and Neck Basaloid Carcinoma.
    Otolaryngol Head Neck Surg. 2024 Apr 12. doi: 10.1002.
    

    >> Share

    
    

    
    PLoS One

27. ZHANG X, Yu J, Zhu J, Wei H, et al
    A meta-analysis of unilateral axillary approach for robotic surgery compared with open surgery for differentiated thyroid carcinoma.
    PLoS One. 2024;19:e0298153.
    

    >> Share

    
    
28. TALANI C, Hogmo A, Laurell G, Makitie A, et al
    Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden.
    PLoS One. 2024;19:e0296534.
    

    >> Share

    
    
29. JIANG W, Xu S, Li P
    SLC2A3 promotes tumor progression through lactic acid-promoted TGF-beta signaling pathway in oral squamous cell carcinoma.
    PLoS One. 2024;19:e0301724.
    

    >> Share

    
    
30. XIE L, He L, Zhang W, Wang H, et al
    Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
    PLoS One. 2024;19:e0298631.
    

    >> Share

    
    
31. SASAKI A, Takeda D, Kawai H, Tadokoro Y, et al
    Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
    PLoS One. 2024;19:e0302194.
    

    >> Share

    
    
32. MONTAGNOLI DRABS, Leite VF, Godoy YS, Lafeta VM, et al
    Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.
    PLoS One. 2024;19:e0302370.
    

    >> Share

    
    

    
    Radiother Oncol

33. DE LEEUW ALMP, Giralt J, Tao Y, Benavente S, et al
    A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE).
    Radiother Oncol. 2024 Apr 16:110281. doi: 10.1016/j.radonc.2024.110281.
    

    >> Share

    
    
34. CHEN AM, Harris JP, Nabar R, Tjoa T, et al
    Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer.
    Radiother Oncol. 2024 Apr 16:110278. doi: 10.1016/j.radonc.2024.110278.
    

    >> Share

    
    
35. ZHENG Z, Shen Y, Su J, Ji X, et al
    Assessing radiation-induced carotid artery injury using ultrasound in patients with head and neck cancer.
    Radiother Oncol. 2024 Apr 17:110285. doi: 10.1016/j.radonc.2024.110285.
    

    >> Share

    
    
36. FITZGERALD KT, Lyons C, England A, McEntee MF, et al
    Risk factors associated with the development of osteoradionecrosis (ORN) in Head and Neck cancer patients in Ireland: A 10-year retrospective review.
    Radiother Oncol. 2024 Apr 17:110286. doi: 10.1016/j.radonc.2024.110286.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share